Publications by authors named "K Tintaya"

Article Synopsis
  • Approximately 40% of global tuberculosis cases go undiagnosed, with lower lung field TB (LLF TB) frequently misidentified as other lung issues, causing treatment delays.
  • An observational study in Lima, Peru, found that among 1316 pulmonary TB patients, 6% had LLF TB, which tended to be smear-negative, indicating a less typical presentation of the disease.
  • LLF TB patients showed less improvement in their respiratory health after 2 months of treatment, yet they had better final treatment outcomes compared to those with non-LLF TB, highlighting the need for optimized care for this specific group.
View Article and Find Full Text PDF

INTRODUCTIONClosing the TB diagnostic gap is an urgent priority, for which non-sputum-based tests are needed. We evaluated the diagnostic accuracy of Aeonose, an exhaled breath test (EBT), as a TB triage test.METHODSPatients with cough or TB risk factors admitted to a tertiary hospital in Lima, Peru, were prospectively enrolled and underwent EBT.

View Article and Find Full Text PDF

Tuberculosis (TB) transmission in healthcare facilities is common in high-incidence countries. Yet, the optimal approach for identifying inpatients who may have TB is unclear. We evaluated the diagnostic accuracy of qXR (Qure.

View Article and Find Full Text PDF

Background: Quantification of recurrence risk following successful treatment is crucial to evaluating regimens for multidrug- or rifampicin-resistant (MDR/RR) tuberculosis (TB). However, such analyses are complicated when some patients die or become lost during post-treatment follow-up.

Methods: We analyzed data on 1991 patients who successfully completed a longer MDR/RR-TB regimen containing bedaquiline and/or delamanid between 2015 and 2018 in 16 countries.

View Article and Find Full Text PDF

Background: Quantification of recurrence risk following successful treatment is crucial to evaluating regimens for multidrug- or rifampicin-resistant (MDR/RR) tuberculosis (TB). However, such analyses are complicated when some patients die or become lost during post-treatment-follow-up.

Methods: We analyzed data on 1,991 patients who successfully completed a longer MDR/RR-TB regimen containing bedaquiline and/or delamanid between 2015 and 2018 in 16 countries.

View Article and Find Full Text PDF